Effect of lipoproteins on cultured human mesangial cells

American Journal of Kidney Diseases

Volumn 29, Issue 6, 1997, Pages 919-930

  Nishida, Yoji ^a   Yorioka, Noriaki ^a   Oda, Hiroaki ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Low density lipoprotein; Mesangial cell proliferation; Oxidized low density lipoprotein; Triglyceride rich lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CELL PROLIFERATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MESANGIUM CELL; PATHOGENESIS; PROLIFERATIVE GLOMERULONEPHRITIS;

EID: 0030965186     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90467-4     Document Type: Article

References (53)

1. Virchow R: A more precise account of fatty metamorphosis, in Gryphonham CF (ed): Cellular Pathology. New York, NY, Gryphon Editions, Dover Publications, 1858, pp 383-408
2. Moorhead JF, Chan MK, El-Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstital disease. Lancet ii:1309-1311, 1982
3. Keane WF: Lipids and the kidney. Kidney Int 46:910-920, 1994
4. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 39:S41-S48, 1991 (suppl 31)
5. Guijarro C, Keane WF: Lipid-induced glomerular injury. Nephron 67:1-6, 1994
6. Gröne EF, Abboud HE, Höhne M, Wali AK, Gröne HJ, Stüker D, Robenek H, Wieland E, Seidel D: Actions of lipoproteins in cultured human mesangial cells: Modulation by mitogenic vasoconstrictors. Am J Physiol 263:F686-F696, 1992
7. Wasserman J, Santiago A, Rifici V, Holthofer H, Scharschmidt L, Epstein M, Schlondorff D: Interactions of low density lipoprotein with rat mesangial cells. Kidney Int 35:1168-1174, 1989
8. Neugarten J, Schlondorff D: Lipoprotein interactions with glomerular cells and matrix, in Keane WF, Stein JH (eds): Contemporary Issues in Nephrology. Lipid and Renal Disease 24. New York, NY, Churchill-Livingstone, 1991, pp 173-206
9. Coritsidis G, Rifici V, Gupta S, Rie J, Shan Z, Neugarten J, Schlondorff D: Preferential binding of oxidised LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 39:858-866, 1991
10. Takemura T, Yoshioka K, Aya N, Murakami K. Matsumoto A, Itakura H, Kodama T, Suzuki H: Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43:918-927, 1993
11. Wheeler DC, Fernando RL, Gillett MPT, Zaruba J, Persaud J, Kingstone D, Varghese Z, Moorhead JF: Characterisation of the binding of low density lipoproteins to cultured rat mesangial cells. Nephrol Dial Transplant 6:701-708, 1991
12. Assmann G, Schulte H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 70:733-737, 1992
13. Nishida Y, Yorioka N, Oda H, Asakimori Y, Amimoto D, Yamakido M: Intermediate density lipoprotein (IDL) is a DNA synthesis stimulation factor in cultured human mesangial cells. Nephron 73:334-335, 1996
14. Kreisberg JI, Karnovsky MJ: Glomerular cells in culture. Kidney Int 23:439-447, 1983
15. Oda H, Yorioka N, Ito T, Yamashita K, Kushihata S, Yamakido M: Nicardipine hydrochloride suppresses DNA synthesis in human mesangial cells stimulated with recombinant human (rh) platelet derived growth factor-AA, rh interleukin-1 α or rh tumor necrosis factor- α. Nephron 73:16-22, 1996
16. Goldstein JL, Basu SK, Brown MS: Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98:241-261, 1983
17. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353, 1955
18. Wheeler DC, Chana RS, Topley N, Petersen MM, Davies M, Williams JD: Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 45:1628-1636, 1994
19. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
20. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G: Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int 46:869-876, 1994
21. Heineche JW, Rosen H, Chait A: Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 74:1890-1894, 1984
22. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86:1372-1376, 1989
23. Morel DW, Hessler JR, Chisolm GM: Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 24:1070-1076, 1983
24. Hodes DS, Heon D, Hass A, Hyatt AC, Kodes HL: Reaction of fungal products with amebocyte lysates of the Japanese horseshoe crab, tachypleus tridentatus. J Clin Microbiol 25:1701-1704, 1987
25. Rovin BH, Tan LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43:218-225, 1993
26. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH: Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 85:37-45, 1992
27. Castell WP: The triglyceride issue: A view from Framingham. Am Heart J 112:432-437, 1986
28. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Mäenpää H, Mälkönen M, Mänttäri M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA: Helsinki heart study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 317:1237-1245, 1987
29. Attman PO, Tavella M, Knight-Gibson C, Samuelsson O, Alaupovic P: Apolipoprotein B-containing lipoprotein particles in progressive renal insufficiency. Contrib Nephrol 98:11-19, 1992
30. Blankenhorn DH, Alaupovic P, Wickham MS, Chin HP, Azen SP: Prediction of angiographic change in native human coronary arteries and aorto-coronary bypass grafts. Circulation 81:470-476, 1990
31. Nestel PJ, Fidge NH, Tan MH: Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 307:329-333, 1982
32. Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, Kametani T, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayama A, Kanaya H, Oiwake H, Genda A, Takeda R: Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 64:1174-1184, 1981
33. Havel RJ, Kane JP: Structure and metabolism of plasma lipoproteins, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease 44A. New York, NY, McGraw-Hill, 1989, pp 1129-1138
34. Diamond JR, Karnovsky MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917-924, 1988
35. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39:S29-S34, 1991 (suppl 31)
36. Wheeler DC, Persaud JW, Fernando RF, Sweny P, Varghese Z, Moorhead JF: Effects of low-density lipoproteins on mesangial cell growth and viability in vitro. Nephrol Dial Transplant 5:185-191, 1990
37. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
38. Takahashi S, Kawarabayashi Y, Nakai T, Sakai J, Yamamoto T: Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89:9252-9256, 1992
39. Schlondorff D: Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22:72-82, 1993
40. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883-3887, 1984
41. Mulcahy WS, Smith JB, Selak M, Krishna GG: Cytotoxicity of low density lipoprotein (LDL) in cultured rat mesangial cells (MC). Kidney Int 37:514, 1990 (abstr)
42. Jürgens G, Hoff HF, Chisolm GM III, Esterbauer H: Modification of human serum low density lipoprotein by oxidation-characterization and pathophysiological implications. Chem Physiol Lipids 45:315-336, 1987
43. Kodama T, Freeman M, Rohrer L. Zabrecky J, Matsudaira P, Krieger M: Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 343:531-535, 1990
44. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 52:223-261, 1983
45. Steinberg D, Parthasarathy S, Carew TE: In vivo inhibition of foam cell development by probucol in Watanabe Rabbits. Am J Cardiol 62:6B-12B, 1988
46. Schönholzer KW, Waldron M, Magil AB: Intraglomerular foam cells and human focal glomerulosclerosis. Nephron 62:130-136, 1992
47. Joven J, Villabona C, Vilella E: Pattern of hyperlipoproteinemia in human nephrotic syndrome: Influence of renal failure and diabetes mellitus. Nephron 64:565-569, 1993
48. Kim SB, Kang SA, Cho YJ, Park SK, Cheong HI, Lee JD, Hong CD, Park JS: Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells. Nephron 67:327-333, 1994
49. Avram MM, Klahr S: Proceedings from the symposium on lipids, hypertension, and nutrition in renal disease. Am J Kidney Dis 26:88-90, 1995
50. Coleman DL, Ruef C: Interleukin-6: An autocrine regulator of meangial cell growth. Kidney Int 41:604-606, 1992
51. Abboud HE: Platelet-derived growth factor and mesangial cells. Kidney Int 41:581-583, 1992
52. Roberts AB, McCune BK, Sporn MB: TGF-β: Regulation of extracellular matrix. Kidney Int 41:557-559, 1992
53. Baud L, Fouqueray B, Philippe C, Amerani A: Tumor necrosis factor alpha and mesangial cells. Kidney Int 41:600-603, 1992